iXCells Biotechnologies appoints Steve Smith as CEO
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services
FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA
Expanded offering provides high-resolution structural insights to support antibody discovery and biologic design
Qureight appoints Rebecca Simmons as Chief Operating Officer
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operations
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P.
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies
FUJIFILM Irvine Scientific now officially FUJIFILM Biosciences
Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors
EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy
Investment from XGEN Venture, British Business Bank, and a global biopharmaceutical company will support first-in-human Phase 1/2a clinical trials for lead candidate EPY201 targeting focal refractory epilepsy (FRE)Future financings to advance a pipeline of transformativ
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearanceResults showed excellent consistency between preclinical and clinical behaviour of ETD001Phase 2 trial
Lab Thread announces Beta release of Unified Lab Software Platform
Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use systemInterested parties invited to register for beta access via the Lab Thre
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
Experienced biotech Chair and executive will guide corporate growth and development
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservationJoint webinar to present trial performance data and best-practice workflows for global research communit
OBN Awards 2025 celebrate the most exciting innovations and inspiring achievements happening across the Life Sciences industry
Abingdon, UK, 27 November 2025: – OBN (UK) Ltd, the membership organisation whose mission is to catalyse success in the life science industry, is thrilled to announce the winners of the 17th annual OBN Awards, an evening organised by
SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform
Automation of Kinnex full-length RNA-seq kit on firefly platform streamlines library preparation for large-scale transcriptomic studiesValidated at Seattle Children’s Genomics & Spatial Biology CoLab, the workflow delivers consistent, high-quality data, supporting t
Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s researchONE BioHub provides Scottish Brain Sciences with infrastructure and integrated support to scale operations and drive forward its pioneering neurologic
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership teamStephen will lead the Company’s scientific strategy, preclinical pipeline build and R&D organisat
Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH
Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver disease
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells
AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual
TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
· Industry leader brings deep expertise across neurodegenerative disease therapeutics development · Dr Hutton joins Prof. Alessio Ciulli FRS and Dr Adam Gilbert on SAB
SPT Labtech and Alithea Genomics collaborate to automate ultra sensitive single-cell transcriptomic workflows
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencingCambridge, UK, and Lausanne, Switzerland, 05 Novem
Optibrium delivers real-time collaboration in its comprehensive molecular design platform with StarDrop 8
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions
